The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 2, 1997, Pages 147-151

  Sorberg M ^a,b   Engstrand, L ^c   Strom M ^b   Jonsson K A ^b   Jorbeck H ^a   Granstrom M ^d  

^a DANDERYD HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MONITORING; PEPTIC ULCER; TIME;

EID: 0030918855     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035875     Document Type: Article

References (19)

1. Dixon MF, Sobala GM. Gastritis and duodenitis: histopathological spectrum. Eur J Gastroenterol Hepatol 4 Suppl 2: 17-23, 1992.
2. Hentschell E, Brantstätter G, Dragosics B, Hirschl A, Nemec H, Schutze K. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328: 308-312, 1993.
3. Passonet J, Freidman GD, Vandersteed DP. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991.
4. Hansson LE, Engstrand L, Nyren O, Evans DJ Jr, Lindgren A, Bergström R. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 105: 1098-1103, 1993.
5. Hansson LE, Engstrand L, Nyren O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 109: 885-888, 1995.
6. Logan RPH. The 13C-UBT for the detection of Helicobacter pylori. In: Rathbone BJ, Heatley RV, eds. Helicobacter pylori and gastroduodenal disease. London: Blackwell Scientific Publications, 88-107, 1992.
7. Kosunen T, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 339: 893-895, 1992.
8. Fendrick AM, Chemew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 123: 260-268, 1995.
9. Jones DM, Eldridge J, Fox A, Sethi P, Whorwell PJ. Antibody to the gastric campylobacter-like organism ("Campylobacter pyloris") - clinical correlations and distribution in the normal population. J Med Microbiol. 22: 57-62, 1986.
10. Veenendaal RA, Pena AS, Meijer JL. Long-term surveillance after treatment of Helicobacter pylori infection. Gut 32: 1291-1294, 1991.
11. Cutler A, Schubert A, Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sciences 38: 2262-2266, 1993.
12. Lelwala-Guruge J, Nilsson I, Ljungh A, Wadstrom T. Cell surface proteins of Helicobacter pylori as antigens in an EIA and a comparison with three commercial EIA. Scand J Infect Dis 24: 457-465, 1992.
13. Megraud F, Rabbe MP, Denis F. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 27: 1870-1873, 1989.
14. Thijs J, Zwet A, Meyer B, Berrelkamp R. Serology to monitor the efficacy of anti-Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 6: 579-583, 1994.
15. Wang W-M, Chen C-Y, Jan C-M, Chen L-T, Perng D-S, Lin S-R, Liu C-S. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer. Am J Gastroenterol 89: 1793-1796, 1994.
16. Hirschl A, Brandstätter G, Dragosics B, Hentschel E, Kundi M, Rotter M, Schutze K, Taufer M. Kinetics of specific antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 168: 763-766, 1993.
17. Cutler A and Prasad M. Long-term follow up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 91: 85-88, 1996.
18. Befrits R, Granström M, Rylander M, Rubio C. Helicobacter pylori in 205 consecutive patients. Scand J Infect Dis 25: 185-191, 1993.
19. Crabtree JE, Wyatt JI, Sobala GM, Millar G, Tompkins DS, Primrose JN. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 34: 1339-1343, 1993.